MedNews: Clinical biopharmaceutical company Sellas Life Sciences, focused on the development of novel therapies for a broad range of cancer indications, raises $21 million
SELLAS is a clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications